This compound is primarily utilized in the synthesis of peptides and small molecules, particularly in pharmaceutical research. It serves as a key intermediate in the development of biologically active compounds, especially those targeting enzyme inhibition or receptor modulation. The tert-butoxycarbonyl (Boc) group acts as a protective group for the amine functionality, allowing selective reactions to occur at other sites of the molecule. Its incorporation into drug candidates is often aimed at enhancing stability, bioavailability, or therapeutic efficacy. Additionally, the presence of the difluorophenyl moiety can contribute to improved binding affinity and metabolic resistance, making it valuable in the design of drugs for conditions such as inflammation, cancer, or central nervous system disorders.